Archive for the ‘Hypertension’ Category
Is there a cure pheochromocytoma and hypertension that occur?
The treatment is surgery to remove the tumor, which are expected to disappear symptoms, although not necessarily correct hypertension, because sometimes coexists with essential hypertension secondary to tumor. What if they disappear are paroxysmal.
Before surgery and especially during this take great care because it can cause a massive release of catecholamines into the bloodstream. Hence it is a complex surgery with a program specific anesthetic.
Sometimes surgery is not possible due to the characteristics of the tumor or at particular risk of the person presenting it, in that case you can set up a medical treatment with drugs that antagonize the effects of catecholamines. Read the rest of this entry »
What are typical symptoms of pheochromocytoma?
There is no specific symptom.
It speaks of the classic triad of pheochromocytoma headache, excessive sweating (diaphoresis) and palpitations that come and go in what is called paroxysmal.
But these symptoms are very common in people with hypertension and do not necessarily obey the “release of catecholamines” by a tumor.
Other symptoms are also nonspecific abdominal pain or chest, the flushing, restlessness or irritability.
Sometimes the paroxysms coincide with urination, and this suggests that the tumor is located in the wall of the bladder and releases hormones when it contracts. Read the rest of this entry »
What is a pheochromocytoma?
It is a tumor that originates from a group of cells called chromaffin (because some are stained with special dyes) involved in the production of different substances, the most important of adrenaline and noradrenaline, which serve to regulate the vascular system.
The highest percentage of these cells are located in the adrenal glands, but can also be found elsewhere in the body. Pheochromocytoma may therefore be an adrenal gland tumor or have a different location (only 10% of these tumors is beyond the gland), usually in the abdomen. Read the rest of this entry »